REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 732.00
Bid: 732.00
Ask: 734.00
Change: 3.00 (0.41%)
Spread: 2.00 (0.273%)
Open: 720.00
High: 735.00
Low: 720.00
Prev. Close: 729.00
BOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Group Chief Executive Appointment

18 Oct 2023 07:00

RNS Number : 4425Q
Bodycote PLC
18 October 2023

www.bodycote.com

18 October 2023

THIS ANNOUNCEMENT IS MADE PURSUANT TO PARAGRAPH 9.6.11R OF THE LISTING RULES AND CONTAINS INSIDE INFORMATION

Bodycote plc

Group Chief Executive Appointment

Bodycote plc ("the Company"), the world's leading provider of heat treatment and specialist thermal processing services, today announces the appointment of Jim Fairbairn as Group Chief Executive to succeed Stephen Harris on his retirement. Jim is expected to join the Company and the Board in March 2024 and become Group Chief Executive in May 2024 following an orderly transition. Stephen will step down from the Board and retire from the Company at the next Annual General Meeting on 31 May 2024.

Jim, 54, has considerable experience in managing engineering businesses, having worked with John Wood Group, PE-owned Clyde Bergemann, Howden Group and Megger Group in a career spanning over three decades, with substantial experience as a Divisional and then Group CEO.

Jim joins Bodycote from test & measurement specialist Megger Group in Dover, which he joined as Group CEO in 2017. Under his leadership, its revenues have materially grown to £325m, with operating margins expanding significantly. He also meaningfully evolved Megger's strategy and culture over this period. Prior to Megger, he held executive positions with Howden Group in Glasgow from 2009-2017, concluding his time there as President of the Howden Power, Environment and Process business with global product and service revenues of over $1 billion with 19 sites worldwide.

During his time in Glasgow, Jim chaired the Glasgow Employer Coalition, helping long-term unemployed into work, for which he was awarded an OBE in 2007. Jim has a degree in Mechanical Engineering from the University of Strathclyde, is a Chartered Engineer, a Fellow of the Royal Academy of Engineering and has an honorary Doctor of Science from City University.

Chair of Bodycote, Daniel Dayan, said:

"The Board is delighted to appoint Jim as Bodycote's next Group Chief Executive. His track record in leading and developing specialist global industrial businesses and teams is outstanding and will enable him to contribute rapidly. His understanding of many of our processes, many of our customers, and the nature of our highly varied markets will be of enormous value. I look forward to working with Jim to drive the continuing development and growth of Bodycote."

Group Chief Executive, Stephen Harris said:

"I am confident Jim has the right skills and experience to continue to drive the Company's strategy and performance over the coming years. In the meantime, I remain focused on the initiatives we have in place to develop and solidify Bodycote's leadership position in its chosen markets."

Jim is currently a member of the Dover Harbour Board and expects to have resigned from that position before starting with Bodycote. There are no other details to disclose relating to Jim Fairbairn under paragraph 9.6.13R of the Listing Rules.

About Bodycote

With more than 165 accredited facilities in 22 countries, Bodycote is the world's largest provider of thermal processing services. Through Specialist Technologies and classical heat treatment, Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including aerospace, defence, automotive, power generation, medical, oil & gas, construction, and transportation. Customers in all of these industries have entrusted their products to Bodycote's care for more than 50 years. For more information, visit www.bodycote.com.

Disclosure

This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU, which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310) ("UK MAR"). Upon the publication of this announcement, this inside information (as defined in UK MAR) is now considered to be in the public domain. The General Counsel of Bodycote is the person responsible for making this disclosure.

For further information, please contact:

Bodycote plc

Daniel Dayan, Chair

Tel: +44 1625 505 300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOADDLFFXBLZFBF
Date   Source Headline
16th Dec 20204:58 pmPRNHolding(s) in Company
10th Dec 20201:36 pmPRNHolding(s) in Company
9th Dec 20202:26 pmPRNHolding(s) in Company
30th Nov 20205:02 pmPRNTotal Voting Rights
27th Nov 20201:09 pmPRNHolding(s) in Company
26th Nov 20207:00 amRNSTrading Update
24th Nov 20208:22 amPRNHolding(s) in Company
11th Nov 20205:05 pmPRNAGM Voting Update
30th Oct 20204:00 pmPRNTotal Voting Rights
27th Oct 20205:10 pmPRNDirector/PDMR Shareholding
9th Oct 20202:57 pmPRNHolding(s) in Company
6th Oct 20207:38 amPRNHolding(s) in Company
30th Sep 20205:05 pmPRNTotal Voting Rights
28th Aug 20205:01 pmPRNTotal Voting Rights
31st Jul 20205:01 pmPRNTotal Voting Rights
31st Jul 20205:01 pmPRNTotal Voting Rights
29th Jul 202012:31 pmPRNHolding(s) in Company
23rd Jul 20207:10 amPRNAppointment of Non-Executive Director
23rd Jul 20207:00 amRNSResults for the six months to 30 June 2020
7th Jul 20203:03 pmPRNHolding(s) in Company
7th Jul 20202:57 pmPRNHolding(s) in Company
30th Jun 20205:00 pmPRNTotal Voting Rights
5th Jun 20202:26 pmPRNDividend Waiver
29th May 20205:00 pmPRNTotal Voting Rights
29th May 20205:00 pmPRNTotal Voting Rights
28th May 202012:37 pmPRNAGM Voting Results
28th May 20207:00 amRNSTrading Update
7th May 20205:30 pmPRNDisclosure of Rights Attached to Equity Shares
30th Apr 20205:00 pmPRNTotal Voting Rights
23rd Apr 20207:00 amPRNNotice of AGM and AGM details
23rd Apr 20207:00 amPRN2019 Dividend and AGM
6th Apr 20207:01 amRNSCORONAVIRUS (COVID-19) UPDATE
6th Apr 20207:00 amRNSAcquisition of Ellison Surface Technologies
31st Mar 20206:00 pmPRNTotal Voting Rights
27th Mar 20204:19 pmPRNAnnual Financial Report
23rd Mar 20204:55 pmPRNHolding(s) in Company
23rd Mar 20201:52 pmPRNDirector/PDMR Shareholding
23rd Mar 20201:49 pmPRNDirector/PDMR Shareholding
17th Mar 20204:20 pmPRNDirector/PDMR Shareholding
17th Mar 20204:17 pmPRNDirector/PDMR Shareholding
16th Mar 202010:17 amPRNHolding(s) in Company
13th Mar 20203:30 pmPRNHolding(s) in Company
12th Mar 20207:00 amRNSFull year results
10th Mar 20204:49 pmRNSHolding(s) in Company
28th Feb 20209:56 amPRNTotal Voting Rights
20th Feb 20203:30 pmPRNHolding(s) in Company
19th Feb 20205:35 pmRNSHolding(s) in Company
13th Feb 20203:07 pmRNSHolding(s) in Company
4th Feb 20203:12 pmPRNHolding(s) in Company
31st Jan 20205:00 pmPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.